Allarity Therapeutics ALLR
NASDAQ ALLR
$0.94 -0.02 (-2.08%)
At close: Nov 9, 2026 · 4:00 PM EST

Allarity Therapeutics (ALLR) Asset Writedowns and Impairment (2022)

Updated

Allarity Therapeutics' Asset Writedowns and Impairment came in at $9.7 million for FY2024.

Analysis

Allarity Therapeutics (ALLR) Asset Writedowns and Impairment (2022) Analysis & Trends

  • Per Business Quant, earlier years put Asset Writedowns and Impairment at $17.57 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 Allarity Therapeutics 14.97 Mn -53.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 3.56 Mn
Mar 31, 2022 14.01 Mn
API Access

Allarity Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=ALLR&period=max&api_key=YOUR_API_KEY